Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments.

Charlotte A BolchHaitao ChuStephanie JarosekStephen R ColeSean ElliottBeth Virnig

Published in: BMC medical research methodology (2017)

Findings suggest that IPT-weighted competing risks analysis provides an accurate estimator of the cumulative incidence of UAE taking into account the competing deaths as well as measured confounding bias.

Keyphrases

prostate cancer
magnetic resonance
magnetic resonance imaging
high resolution
radical prostatectomy
computed tomography
risk assessment
smoking cessation
replacement therapy
data analysis